Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1

Interventions

salicylsalicylic acid 1XENP 1595 1Pioglitazone 1Interleukin 1 Receptor Antagonist Protein 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Inflammation × salicylsalicylic acid × Clear all
NCT01489319 2017-02-10

ELI-ROAS

Indiana University

Phase 1 Terminated
47 enrolled

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡